08 Jan, EOD - Indian

SENSEX 78148.49 (-0.06)

Nifty 50 23688.95 (-0.08)

Nifty Bank 49835.05 (-0.73)

Nifty IT 43634.25 (0.60)

Nifty Midcap 100 56270.6 (-1.05)

Nifty Next 50 66402.6 (-0.80)

Nifty Pharma 23011.1 (-0.94)

Nifty Smallcap 100 18365.65 (-1.65)

08 Jan, EOD - Global

NIKKEI 225 39981.06 (-0.26)

HANG SENG 19279.84 (-0.86)

S&P 5909.45 (-0.08)

LOGIN HERE

companylogoCamlin Fine Sciences Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532834 | NSE Symbol : CAMLINFINE | ISIN : INE052I01032 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
31-Dec-2024 02-Jan-2025 Right Issue Inter alia, to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue Outcome of the meeting of the Securities Issue and Allotment Committee of the Board of Directors of Camlin Fine Sciences Limited (the 'Company') held on January 2, 2025. (As Per BSE Announcement Dated on 02.01.2025)
18-Nov-2024 22-Nov-2024 Right Issue CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/11/2024 inter alia to consider and approve the revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and Issue of any debt securities of the Company. We wish to inform you that the Board of Directors of the Company at its meeting held today, i.e., Friday, November 22, 2024, inter alia, considered and approved the revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and The proposal for fund raising by way of issuance of up to 10,000 (Ten Thousand) senior, secured, redeemable, unlisted, unrated, non-convertible debentures of face value of Rs. 100,000 (Rupees One Lakh only) each ('NCDs') aggregating for an amount of Rs. 100,00,00,000 (Rupees One Hundred Crores only) on a private placement basis. (As Per BSE Announcement dated on 22.11.2024)
28-Oct-2024 11-Nov-2024 Quarterly Results Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidate Financial Results of the Company for the quarter and half year ended September 30, 2024. (As Per BSE Announcement dated on 28.10.2024) Unaudited Financial Results - 30.09.2024 (As Per BSE Announcement Dated on: 11/11/2024)
05-Sep-2024 10-Sep-2024 Increase in Authorised Capital CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2024 inter alia to consider and approve the proposal for raising of funds by way of rights issue of equity shares under applicable laws or issue of any other securities of the Company Outcome of the Board Meeting - Approval for fund raising proposal For the purposes of giving effect to the rights issue, the detailed terms to the rights issue including but not limited to issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course by the Board, or the Securities Issue and Allotment Committee' constituted by the Board, in accordance with applicable laws, subject to receipt of necessary approvals, as may be required. Outcome of the Board Meeting - Approval for fund raising proposal (As Per BSE Announcement dated on 10.09.2024)
05-Aug-2024 12-Aug-2024 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter ended June 30 2024. UFR 30.06.2024 (As Per BSE Announcement Dated on: 12/08/2024)
08-May-2024 20-May-2024 Accounts CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 inter alia to consider and approve Intimation about the Board Meeting to be held on May 20 2024 to consider and approve the standalone and consolidated audited financial results for the quarter / year ended March 31 2024 AFR 31st March, 2024 Appointment of Secretarial Auditor and Cost Auditor for FY 2024 - 2025 (As Per BSE Announcement dated on 20.05.2024)
29-Jan-2024 09-Feb-2024 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve To consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter and nine months ended December 31 2023 Unaudited Financial Results 31.12.2023 (As per BSE Announcement Dated on 09/02/2024)
25-Oct-2023 06-Nov-2023 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve To consider and approve the standalone and consolidated un-audited financial results for the quarter and half year ended September 30 2023. Un- audited Financial Results - 30th September, 2023 Appointment of Chief Operating Officer Outcome of Board Meeting (As per BSE Announcement Dated on 06/11/2023)
01-Aug-2023 11-Aug-2023 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve Intimation about the Board Meeting of Camlin Fine Sciences Limited (the Company) to be held on August 11 2023 Un-audited Financial Results - 30th June, 2023 Outcome of Board Meeting (As Per BSE Announcement Dated on 11.08.2023)
02-May-2023 22-May-2023 Accounts CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 inter alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter / year ended March 31 2023. Audited Financial Results 31st March, 2023 Outcome of Board Meeting (As Per BSE Announcement dated on 22.05.2023)
03-Feb-2023 13-Feb-2023 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Intimation about the Board Meeting of Camlin Fine Sciences Limited (the Company) to be held on February 13 2023 Un-audited Financial Results Q.E. 31st December, 2022 (As Per BSE Announcement Dated on 13/02/2023)
04-Nov-2022 12-Nov-2022 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Intimation about the Board Meeting of Camlin Fine Sciences Limited (the Company) to be held on November 12 2022 UFR 30th September, 2022 (As Per BSE Announcement Dated 12.11.2022)
02-Aug-2022 12-Aug-2022 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Intimation about the Board Meeting of Camlin Fine Sciences Limited (the Company) to be held on August 12 2022 UFR 30TH JUNE 2022 outcome of Board Meeting (As per BSE Announcement Dated on 12/08/2022)
06-May-2022 19-May-2022 Accounts CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 inter alia to consider and approve Intimation about the Board Meeting of Camlin Fine Sciences Limited (the Company) to be held on May 19 2022 Audited Financial Results 31st March, 2022 Outcome of Board Meeting Book Closure for Annual General Meeting Recommendation for Reappointment of Statutory Auditor (As per BSE Announcement Dated on 19/5/2022)
28-Jan-2022 07-Feb-2022 Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 inter alia to consider and approve Un-audited Financial Results for the quarter & nine months ended on December 31 2021 Outcome of Board Meeting UFR 31st December, 2021 (As Per BSE Announcement dated on 07.02.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +